{
    "code": "02022860",
    "許可證字號": "衛署藥輸字第022860號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/09\/21",
    "註銷理由": "屆期未申請展延",
    "有效日期": "94\/04\/25",
    "發證日期": "89\/04\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202286000",
    "中文品名": "憶思能膠囊０．５公絲",
    "英文品名": "EXELON CAPSULES 0.5MG",
    "適應症": "輕度至中度阿滋海默氏病之癡呆（失智）症。",
    "劑型": "130膠囊劑",
    "包裝": "玻璃容器裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "RIVASTIGMINE HYDROGEN TARTRATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1422701100  臺灣諾華股份有限公司",
    "申請商地址": "台北巿大安區仁愛路２段９９號１１Ｆ",
    "主製造廠": {
        "製造廠名稱": "F430088000  NOVARTIS PHARMA AG",
        "製造廠廠址": "CH-4332,STEIN,SWITZERLANDCH-4002,BASEL,SWITZERLAND",
        "製造廠公司地址": "CH-4002,BASEL,SWITZERLAND",
        "製造廠國別": "SWITZERLAND",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1204001410",
            "成分名稱": "RIVASTIGMINE HYDROGEN TARTRATE",
            "含量描述": "0.8",
            "含量": "0.8000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "明黃橙\/淡黃",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "長圓柱形",
        "標記一": "EXELON,0.5mg",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "圖片",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02022860&Seq=435&Type=10"
        }
    ]
}